A subtype of cancer-associated fibroblast expressing syndecan-2 (SDC2) predicts survival and immune checkpoint inhibitor response in gastric cancer.

ABSTRACT:

SUBMITTER: Sung JY 

PROVIDER: S-EPMC11645442 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature